191 Afleveringen

  1. Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)

    Gepubliceerd: 27-6-2018

  2. Self-Evaluation: Special histologies - lymphoma: Primary CNS, appropriate first line therapy for newly diagnosed primary CNS lymphoma

    Gepubliceerd: 20-6-2018

  3. ASCO Guideline: Fertility Preservation in Patients with Cancer

    Gepubliceerd: 13-6-2018

  4. Self-Evaluation: EGFR Mutation

    Gepubliceerd: 6-6-2018

  5. Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer

    Gepubliceerd: 30-5-2018

  6. ASCO Guidelines: Outpatient Management of Fever and Neutropenia

    Gepubliceerd: 23-5-2018

  7. Self-Evaluation: NSCLC Treatment Metastatic

    Gepubliceerd: 16-5-2018

  8. Adjuvant Treatment in Melanoma: Recent Advances

    Gepubliceerd: 9-5-2018

  9. Recently Approved Drugs: Blinatumomab for B-cell precursor ALL

    Gepubliceerd: 2-5-2018

  10. Guidelines: Management of Immune-Related Adverse Events

    Gepubliceerd: 25-4-2018

  11. Treatment Effects & Transition to Survivorship for AYA Patients

    Gepubliceerd: 18-4-2018

  12. EHR Chemotherapy Error: Breast Cancer

    Gepubliceerd: 11-4-2018

  13. Continuity of Care for AYAs

    Gepubliceerd: 4-4-2018

  14. Self-Evaluation: Clinical Trials Informed Consent Process

    Gepubliceerd: 28-3-2018

  15. Self-Evaluation: Clinical Trials

    Gepubliceerd: 14-3-2018

  16. Self-Evaluation: NSCLC

    Gepubliceerd: 14-2-2018

  17. Self-Evaluation: Breast Cancer

    Gepubliceerd: 7-2-2018

  18. Self-Evaluation: Metastatic Breast Cancer

    Gepubliceerd: 13-12-2017

  19. ASCO Guidelines: Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer Update

    Gepubliceerd: 6-12-2017

  20. Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer

    Gepubliceerd: 22-11-2017

9 / 10

ASCO Education: By the Book features engaging discussions between editors and authors from the ASCO Educational Book. Hear nuanced views on topics featured in Education Sessions at ASCO meetings and deep dives on the approaches shaping modern oncology that have care teams talking.

Visit the podcast's native language site